GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve …
Jul 2, 2012 · Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the Justice ...
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 …
Oct 9, 2024 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
Office of Public Affairs | GlaxoSmithKline to Plead Guilty & Pay …
Oct 26, 2010 · Under the civil settlement, GSK has agreed to pay an additional $600 million to the federal government and the states to resolve claims that it caused false claims to be submitted to government health care programs for certain quantities of adulterated Kytril, Bactroban, Paxil CR and Avandamet.
Glaxo settles record whistleblower case for $3 billion
Jul 2, 2012 · In their qui tam lawsuit, Gerahty and Burke provided detailed allegations about numerous off-label treatments pushed by Glaxo across the country for six of its most popular drugs, along with concrete evidence to support those allegations.
GlaxoSmithKline settles healthcare fraud case for $3 billion
Jul 3, 2012 · GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay $3 billion to settle the largest case of healthcare fraud in U.S. history, according to court filings and...
GlaxoSmithKline Settles Most Zantac Lawsuits for $2.2B - Law.com
Oct 9, 2024 · GlaxoSmithKline has agreed to pay up to $2.2 billion to settle 80,000 Zantac lawsuits. Wednesday's announcement resolves 93% of all Zantac cases in state courts against GSK.
Attorney General Kamala D. Harris Secures $105 Million Multistate ...
Jun 4, 2014 · SAN FRANCISCO – Attorney General Kamala D. Harris today announced a $105 million multistate settlement with GlaxoSmithKline, LLC (GSK) to resolve allegations that the company unlawfully promoted its asthma drug, Advair, and …
GSK soothes investors by settling first Zantac cancer lawsuit due …
Jun 23, 2023 · GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer, the British drugmaker said on Friday, preventing the first such case from going to...
Statement: Zantac (ranitidine) litigation – settlement ... - GSK
Oct 9, 2024 · GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac product liability cases for up to $2.2 billion. Separate settlement of qui tam complaint for $70 million. Settlements agreed with no admission of liability.
After Delaware decision, GSK faces $2B to settle Zantac lawsuits
Jun 3, 2024 · The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer...